Late-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Early findings suggest the drug, which is already approved for MS symptoms, could slash the risk of people with no symptoms but who have signs of nerve damage on MRI scans.
GSK said Bellus’ experimental cough medicine could help treat millions of people with untreatable chronic coughs and had “significant sales potential” if approved.
The test, capable of detecting Parkinson’s before the onset of symptoms, “launches a new, biological era in Parkinson’s research” and could pave the way for a cure, said researcher Kenneth Marek.
Gun violence disproportionately affects people of color, a Kaiser Family Foundation poll found and more than half of Americans say they have dealt with gun violence at some point in their personal lives.
Exposure to certain pets in early infancy appears to protect against various food allergies, a study has found, while others appear to increase rates of nut allergies.